Category: pharma & healthcare

U.K.’s Voluntary Scheme For Branded Medicines, Pricing, And Access (VPAS) Faces A Potential Crisis

Two large U.S.-based drug companies – AbbVie and Eli Lilly – have now exited the voluntary drug price agreement, citing the “punitive” system of revenue clawbacks, which has risen to 26.5% of branded sales in 2022. And, AbbVie and Lilly aren’t the only…

Bivalent Antibodies For Covid-19: Two Hands Are Better Than One

A certain subset of monoclonal antibodies – those that bind bivalently – are much more effective against the latest strains of Omicron.

DTC Advertising Of Prescription Drugs In The U.S. Often Promotes Products With Comparatively Low Therapeutic Value

Fewer than one-third of the most commonly advertised drugs were rated as having “high therapeutic value,” defined as providing at least moderate improvement in clinical outcomes relative to existing treatment alternatives.

Progress In Tissue Engineering: Controlling Cell-Cell Signaling

A recent study reveals the potential of harnessing cell to cell communication to advance tissue engineering.

Inflation Reduction Act Favors Biologics Over Small Molecules: In The Long Term, This Could Partly Undermine Bill’s Effort To Contain Costs

Because the Inflation Reduction Act gives small molecule drugs a shorter, 9-year post-approval window before their “fair prices” are implemented, executives in the pharmaceutical industry have argued that the IRA will “harm innovation,” in particular, …

‘Shot In The Arm’ Shows How Disinformation Can Be Deadly

Vaccine-preventable diseases like polio and measles are on the rise because more and more parents aren’t vaccinating their kids. ‘Shot in the Arm’ clearly shows why disinformation itself is a disease.

Emergence Of IgG4 In Long-Term Vaccines: Winning Or Losing The Race?

An uncommon type of antibody is on the rise after multiple vaccinations or infections. Here we discuss what this could mean.

As CMS Asks For The Public’s Feedback On Implementing The Inflation Reduction Act, Unresolved Issues Related To Drug Price Negotiations Remain

On January 11, CMS announced a timeline for implementation of the IRA’s drug pricing provisions, including price negotiations. CMS is enlisting the public’s feedback throughout the process of price negotiations. As CMS asks for the public’s help, sever…

More Than A Gut Feeling

The pleasure of eating begins in the mouth, albeit extends far beyond it. From the first bite to the moment that waste is released, the brain is receiving signals from olfactory and gustatory receptors throughout the digestive system.

You Can Now Control A Wheelchair With Your Brain Waves Alone

A completely non-invasive technology allows people to control a wheelchair simply by using their minds and a cap that decodes their brain waves.